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General Methods and Materials 
 
General: All biotransformations were carried out in HEPES buffer (100 mM pH 10.9) unless 
otherwise stated and were incubated at 30 °C and 200 rpm. 1H and 13C NMR spectra were 
recorded on a Bruker DPX 400 or Bruker AV(III)500 spectrometer (400 MHz for 1H and 
100.3 MHz for 13C) in CDCl3 or D2O. The chemical shifts are reported in ppm with the 
residual solvent referenced to 7.26 ppm/77.23 ppm (1H/13C CDCl3) and 4.79 ppm (
1H D2O) 
respectively. Coupling constants (J) are reported in Hz and refer to the observed peak 
multiplicities. 13C ppm values are rounded up and reported to one decimal place. GC-FID 
analysis was performed on a Bruker Trace 1310 series GC equipped with an autosampler 
and chirasil Dex CB (25 m x 0.25 mm x 0.25 mm) column. Mass spectra were recorded on a 
Bruker MicroTOF II spectrometer (ESI). 
Materials: Commercially available reagents were used throughout without further 
purification. Reagents were purchased from Sigma Aldrich, Acros and Merck Millipore. 
Commercially available ATA 256 was a gift from Codexis®.  
 
Analytical biotransformation of Ketones 7-9 with ATA 256 and amine donors 4-5.  
Commercially available (S)-selective ATA 256 (2.5 mg/mL) was rehydrated in HEPES buffer 
(1 mL, 100 mM, pH 10.9) containing PLP (1 mM) and amines 4-5 (60 mM from a 500 mM 
stock in HEPES buffer). For comparison, isopropylamine was also tested under the same 
reaction conditions. The ketone substrate was added (20 mM from a 500 mM stock in 
DMSO) and the reaction pH adjusted to 10.9. The mixture was incubated at 30° C for 48 
hours in a shaking incubator (200 rpm). The reactions were analysed by GC-FID following 
extraction of the basified (pH 12 adjusted with conc. NaOH) solution (500 µL) with EtOAc (1 
x 750 μL) and derivatisation (10 μL Ac2O, 10 μL TEA).  
 
Preparative scale biotransformation of acetophenone 8 with ATA 256 and cadaverine 
4 (1,5-diaminopropane) 
Commercially available (S)-selective ATA 256 (2.5 mg/mL) was rehydrated in HEPES buffer 
(10 mL, 100 mM, pH 10.9) containing PLP (1 mM) and cadaverine (150 mM from a 500 mM 
stock in HEPES buffer). To this was added acetophenone (50 mM from a 500 mM stock in 
DMSO) and the mixture was incubated at 30° C for 48 hours in a shaking incubator (200 
rpm). The mixture was then adjusted to pH 4.0 and extracted with diethyl ether (30 mL). The 
aqueous solution was then adjusted to pH 12 and extracted with diethyl ether (30 ml x 2). 
The combined organic fractions were reduced in vacuo and dissolved in ethyl acetate (5 mL) 
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and filtered through a small plug of silica, which was washed with a further portion of ethyl 
acetate (5 ml). The solvent was combined and concentrated in vacuo to give (S)-
methylbenzylamine (39 mg, 64 % yield). 1H NMR (400 MHz, Chloroform-d) δ 7.37 – 7.19 (m, 
5H), 4.11 (q, J = 6.6 Hz, 1H), 1.70 – 1.58 (m, 2H), 1.39 (d, J = 6.6 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ 147.8, 128.5, 126.8, 125.7, 51.4, 25.7. In accordance with literature data.
 [1] 
 
Analytical scale biotransformation of 1-aminoindane 15 with ATA 256 and 
isotripiperideine 14 
Commercially available (S)-selective ATA 256 (2.5 mg/mL) was rehydrated in HEPES buffer 
(1 mL, 100 mM, at pH 8.0, 9.0 10.0 and 10.9) containing PLP (1 mM) and isotripiperideine 
14 (40 mM from a 125 mM stock in HEPES buffer). To this was added 1-aminoindane 15 (20 
mM from a 500 mM stock in DMSO) and the mixture incubated at 30 °C for 48 hours in a 
shaking incubator (200 rpm). The reactions were analysed by GC-FID following extraction of 
the basified (pH 12 adjusted with conc. NaOH) solution (500 µL) with EtOAc (1 x 750 μL) 
and derivatisation (10 μL Ac2O, 10 μL TEA). 
 
Synthesis of α-Tripiperideine 12[2,3] 
N-Chlorosuccinimide (3.29 g, 24.66 mmol, 1.05 eq) was stirred in Et2O (25 mL) and cooled 
in an ice-bath. Piperidine (2.32 mL, 23.49 mmol) was then added slowly over 5 minutes and 
left to stir at room temperature for two hours. The mixture was filtered and the resulting 
filtrate washed with water and dried with MgSO4  and reduced in vacuo to approx. 1/3 volume 
(without heating)* to give 1-chloropiperidine as a crude yellow oil. This oil was dissolved in 
EtOH (15 mL) and to this was added potassium hydroxide (3.1 g, 55 mmol). This mixture 
was then refluxed for a further two hours, filtered and the solvent removed in vacuo to give a 
thick yellow oil Δ1-piperideine (1.33g, 15.97 mmol, 68% over two steps). 1H NMR (300 MHz, 
Chloroform-d) δ 3.16 – 3.03 (m, 3H), 2.83 – 2.72 (m, 3H), 2.05 – 1.91 (m, 3H), 1.76 – 1.60 
(m, 9H), 1.60 – 1.47 (m, 6H), 1.32 – 1.20 (m, 3H); 13C NMR (75 MHz, Chloroform-d) δ 82.0, 
46.5, 29.3, 25.9, 22.4; (m/z) calculated C15H27N3 [M] 249.2205; found 249.2135. 
*Potentially hazardous/explosive  
 
Conversion of Δ1-Piperideine 13 to Isotripiperideine 14.[2,3,4] 
Δ1-piperideine (1 g, 4.01 mmol) was dissolved in acetone (2 mL) and the solution was left to 
crystallise over 5 days at -20 °C. The resulting crystals were washed with water and Et2O to 
give clear crystals of isotripiperideine 14 (810 mg, 3.25 mmol) suitable for x-ray 
crystallographic analysis. 1H NMR (500 MHz, Chloroform-d) δ 3.77 – 3.67 (m, 1H), 3.15 – 
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3.08 (m, 2H), 2.67 – 2.51 (m, 3H), 1.98 – 1.69 (m, 8H), 1.68 – 1.46 (m, 4H), 1.39 – 1.14 (m, 
5H), 0.96 (m, 1H); 13C NMR (101 MHz, CDCl3) δ 82.0, 81.2, 64.2, 48.0, 48.0, 45.7, 43.7, 
29.8, 28.7, 27.7, 26.5, 26.2, 25.4, 23.4, 23.4; (m/z) calculated for C15H27N3 [M+H] 250.2278; 
found 250.2277. 
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Figure S1: Overlay of spectra from the large-scale reaction of acetaphenone 8 with ATA256 
employing cadaverine 4 as the amine donor showing the presence of the trimeric by-product. 
A) Purified large scale reaction showing (S)-methylbenzylamine. B) Synthesised and purified 
isotripiperideine 14. C) Crude NMR of large scale enzyme reaction, showing both 
isotripiperideine 14 and (S)-methylbenzylamine before purification. 
 
Crystal Data for C15H27N3 (M =249.39 g/mol): monoclinic, space group C2/c (no. 15), a = 
10.06270(12) Å, b = 16.75395(15) Å, c = 16.98045(18) Å, β = 97.0391(10)°, V = 
2841.16(5) Å3, Z = 8, T = 120(2) K, μ(CuKα) = 0.531 mm-1, Dcalc = 1.166 g/cm3, 36653 
reflections measured (10.312° ≤ 2Θ ≤ 148.41°), 2871 unique (Rint = 0.0341, Rsigma = 0.0099) 
which were used in all calculations. The final R1 was 0.0560 (I > 2σ(I)) and wR2 was 0.1651 
(all data). Single crystals of C15H27N3 14 were obtained as detailed above. A suitable crystal 
(0.408 × 0.266 × 0.205mm) was selected and mounted in fomblin film on a MiTeGen 
micromount on a Rigaku Oxford Diffraction single source SuperNova TitanS2 diffractometer, 
using Cu-Kα radiation (λ = 1.54184 Å). The crystal was kept at 120(2) K during data 
collection. Using Olex2,5 the structure was solved with the olex2.solve6 structure solution 
program using Charge Flipping and refined with the ShelXL7 refinement package using 
Least Squares minimisation; (CCDC 1471632). 
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